Khaberni - Researchers from Radboud University Medical Center and the University of Basel have discovered new genetic causes ...

STOCKHOLM — Trial results are demonstrating the safety and effectiveness of a novel gene modifier therapy for treating retinitis pigmentosa associated with NR2E3 and RHO mutations. Researchers ...

Retinitis is an eye condition where the tissue at the back of the eyeball becomes inflamed. It can lead to reduced vision and vision loss. The tissue at the back of the eye is known as the retina. It ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. There were no reports of serious adverse events with MCO ...

LEXINGTON, Mass.--(BUSINESS WIRE)-- Aldeyra Therapeutics, Inc. (ALDX) (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation for ...